Avantax Advisory Services, Inc. Coh Bar, Inc. Transaction History

Avantax Advisory Services, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$0.17 - $0.34 $6,545 - $13,090	38,500 New	38,500 $7,000
Q1 2022 Apr 27, 2022	SELL	$0.25 - $0.43 $2,500 - $4,300	-10,000 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$1.09 - $1.49 $10,900 - $14,900	10,000 New	10,000 $14,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Advisory Services, Inc. with notifications on news.